Susquehanna International Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$67.9M Buy
208,262
+137,797
+196% +$44.9M 0.01% 151
2025
Q1
$19M Buy
70,465
+59,648
+551% +$16.1M ﹤0.01% 374
2024
Q4
$2.55M Sell
10,817
-152,917
-93% -$36M ﹤0.01% 1686
2024
Q3
$45M Buy
163,734
+96,723
+144% +$26.6M 0.01% 188
2024
Q2
$16.3M Sell
67,011
-14,651
-18% -$3.56M ﹤0.01% 466
2024
Q1
$12.2M Buy
81,662
+55,655
+214% +$8.32M ﹤0.01% 550
2023
Q4
$4.98M Sell
26,007
-162,346
-86% -$31.1M ﹤0.01% 1148
2023
Q3
$33.4M Buy
188,353
+98,823
+110% +$17.5M 0.01% 275
2023
Q2
$17M Sell
89,530
-24,871
-22% -$4.72M ﹤0.01% 475
2023
Q1
$22.9M Buy
114,401
+83,736
+273% +$16.8M ﹤0.01% 405
2022
Q4
$7.29M Sell
30,665
-11,752
-28% -$2.79M ﹤0.01% 761
2022
Q3
$8.49M Sell
42,417
-21,011
-33% -$4.21M ﹤0.01% 572
2022
Q2
$9.25M Sell
63,428
-20,319
-24% -$2.96M ﹤0.01% 592
2022
Q1
$13.7M Sell
83,747
-59,208
-41% -$9.67M ﹤0.01% 570
2021
Q4
$24.2M Buy
142,955
+98,562
+222% +$16.7M ﹤0.01% 383
2021
Q3
$8.38M Sell
44,393
-63,788
-59% -$12M ﹤0.01% 854
2021
Q2
$18.3M Buy
108,181
+41,507
+62% +$7.04M ﹤0.01% 558
2021
Q1
$9.41M Sell
66,674
-12,254
-16% -$1.73M ﹤0.01% 814
2020
Q4
$10.3M Buy
78,928
+40,709
+107% +$5.29M ﹤0.01% 641
2020
Q3
$5.56M Buy
38,219
+25,493
+200% +$3.71M ﹤0.01% 783
2020
Q2
$1.89M Sell
12,726
-26,153
-67% -$3.87M ﹤0.01% 1511
2020
Q1
$4.23M Buy
38,879
+402
+1% +$43.8K ﹤0.01% 791
2019
Q4
$4.43M Sell
38,477
-69,857
-64% -$8.05M ﹤0.01% 917
2019
Q3
$8.71M Buy
108,334
+9,067
+9% +$729K ﹤0.01% 465
2019
Q2
$7.2M Buy
99,267
+84,204
+559% +$6.11M ﹤0.01% 517
2019
Q1
$1.41M Sell
15,063
-66,766
-82% -$6.24M ﹤0.01% 1033
2018
Q4
$5.97M Sell
81,829
-7,405
-8% -$540K ﹤0.01% 433
2018
Q3
$7.81M Buy
89,234
+48,210
+118% +$4.22M ﹤0.01% 426
2018
Q2
$4.04M Buy
41,024
+1,729
+4% +$170K ﹤0.01% 684
2018
Q1
$4.68M Sell
39,295
-113,975
-74% -$13.6M ﹤0.01% 524
2017
Q4
$19.5M Buy
153,270
+142,394
+1,309% +$18.1M 0.01% 208
2017
Q3
$1.28M Sell
10,876
-90,747
-89% -$10.7M ﹤0.01% 1477
2017
Q2
$8.11M Sell
101,623
-63,375
-38% -$5.06M ﹤0.01% 366
2017
Q1
$8.46M Buy
164,998
+25,827
+19% +$1.32M ﹤0.01% 310
2016
Q4
$5.21M Buy
+139,171
New +$5.21M ﹤0.01% 587
2016
Q3
Hold
0
2935
2016
Q2
Sell
-20,859
Closed -$1.31M 3155
2016
Q1
$1.31M Buy
20,859
+1,945
+10% +$122K ﹤0.01% 1716
2015
Q4
$1.78M Sell
18,914
-138,272
-88% -$13M ﹤0.01% 1675
2015
Q3
$12.6M Buy
157,186
+18,541
+13% +$1.49M 0.01% 400
2015
Q2
$16.6M Buy
138,645
+85,034
+159% +$10.2M 0.01% 381
2015
Q1
$5.6M Buy
53,611
+41,504
+343% +$4.33M ﹤0.01% 773
2014
Q4
$1.17M Sell
12,107
-14,229
-54% -$1.38M ﹤0.01% 2449
2014
Q3
$2.06M Buy
26,336
+3,828
+17% +$299K ﹤0.01% 1691
2014
Q2
$1.42M Sell
22,508
-34,377
-60% -$2.17M ﹤0.01% 2073
2014
Q1
$3.82M Sell
56,885
-3,349
-6% -$225K ﹤0.01% 1104
2013
Q4
$3.88M Buy
60,234
+34,783
+137% +$2.24M ﹤0.01% 1176
2013
Q3
$1.63M Buy
+25,451
New +$1.63M ﹤0.01% 1662
2013
Q2
Hold
0
3483